Dr. Chokye on Using an MRI for the Detection of Prostate Cancer

Peter Chokye, MD, FACR
Published Online: Monday, May 15, 2017



Peter Chokye, MD, FACR, chief of the Molecular Imaging Program, National Cancer Institute, discusses using an MRI for the detection of patients with prostate cancer.

According to Chokye, an MRI is the best modality for detecting larger cancers. It has been clearly shown that using an MRI can detect more of the high-grade cancers, achieving a more accurate diagnosis.

This is helpful for making decisions such as when a patient should go on active surveillance versus treatment and when to use surgery versus radiation therapy, explains Chokye.
 


Peter Chokye, MD, FACR, chief of the Molecular Imaging Program, National Cancer Institute, discusses using an MRI for the detection of patients with prostate cancer.

According to Chokye, an MRI is the best modality for detecting larger cancers. It has been clearly shown that using an MRI can detect more of the high-grade cancers, achieving a more accurate diagnosis.

This is helpful for making decisions such as when a patient should go on active surveillance versus treatment and when to use surgery versus radiation therapy, explains Chokye.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Genitourinary CancersJul 28, 20171.5
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication